(Q79345593)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17096072%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

editorial

0 references

title

Renin-angiotensin system and progression of chronic liver diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17096072%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

main subject

chronic liver disease

0 references

author name string

Hitoshi Yoshiji

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17096072%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Hiroshi Fukui

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17096072%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

publication date

1 October 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17096072%20AND%20SRC:MED&resulttype=core&format=json

Journal of Gastroenterology

21 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17096072%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17096072%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17096072%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

1020-1022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17096072%20AND%20SRC:MED&resulttype=core&format=json

Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis

21 December 2019

cites work

1 reference

12 December 2020

Host genetic factors influence disease progression in chronic hepatitis C.

1 reference

12 December 2020

The role of vasoactive mediators in portal hypertension.

1 reference

12 December 2020

Liver fibrogenesis: a new role for the renin-angiotensin system

1 reference

12 December 2020

Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis

1 reference

12 December 2020

Tumor-selective blood flow decrease induced by an angiotensin converting enzyme inhibitor, temocapril hydrochloride.

1 reference

12 December 2020

Effect of angiotensin receptor antagonist on liver fibrosis in early stages of chronic hepatitis C.

1 reference

12 December 2020

Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis

1 reference

12 December 2020

Expression of vascular endothelial growth factor in human hepatocellular carcinoma

1 reference

12 December 2020

Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats.

1 reference

12 December 2020

Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor

1 reference

12 December 2020

Combination of interferon-beta and angiotensin-converting enzyme inhibitor, perindopril, attenuates the murine liver fibrosis development.

1 reference

12 December 2020

Expression of angiotensin II type 1 receptor in human cirrhotic livers: Its relation to fibrosis and portal hypertension.

1 reference

12 December 2020

Combination of interferon-beta and the angiotensin-converting enzyme inhibitor, perindopril, attenuates murine hepatocellular carcinoma development and angiogenesis.

1 reference

12 December 2020

Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice

1 reference

12 December 2020

Halting the interaction between vascular endothelial growth factor and its receptors attenuates liver carcinogenesis in mice.

1 reference

12 December 2020

Angiotensin-I converting enzyme inhibitors as potential anti-angiogenic agents for cancer therapy.

1 reference

12 December 2020

Inhibition of renin-angiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in rats.

1 reference

12 December 2020

Combination of vitamin K2 and the angiotensin-converting enzyme inhibitor, perindopril, attenuates the liver enzyme-altered preneoplastic lesions in rats via angiogenesis suppression

1 reference

12 December 2020

Beneficial effect of angiotensin-blocking agents on graft fibrosis in hepatitis C recurrence after liver transplantation.

1 reference

12 December 2020

Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II.

1 reference

12 December 2020

Endothelial cell marker expression in dysplastic lesions of the liver: an immunohistochemical study.

1 reference

12 December 2020

Angiogenesis in life, disease and medicine

1 reference

12 December 2020

Suppression of renin-angiotensin system attenuates hepatocarcinogenesis via angiogenesis inhibition in rats

1 reference

12 December 2020

Chronic viral hepatitis induced by hepatitis C but not hepatitis B virus infection correlates with increased liver angiogenesis

1 reference

12 December 2020

Angiotensin II induces contraction and proliferation of human hepatic stellate cells

1 reference

12 December 2020

Angiotensin-II and vascular endothelial growth factor interaction plays an important role in rat liver fibrosis development

1 reference

12 December 2020

Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma

1 reference

12 December 2020

Anti-fibrogenic effect of an angiotensin converting enzyme inhibitor on chronic carbon tetrachloride-induced hepatic fibrosis in rats

1 reference

12 December 2020

Imatinib mesylate (STI-571) attenuates liver fibrosis development in rats.

1 reference

12 December 2020

AT1A-deficient mice show less severe progression of liver fibrosis induced by CCl(4).

1 reference

12 December 2020

Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese.

1 reference

12 December 2020

Role of angiotensin II in regulation of basal and sympathetically stimulated vascular tone in early and advanced cirrhosis

1 reference

12 December 2020

Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats.

1 reference

12 December 2020

Angiotensin-II induces the tissue inhibitor of metalloproteinases-1 through the protein kinase-C signaling pathway in rat liver fibrosis development

1 reference

12 December 2020

10.1007/S00535-006-1897-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17096072%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference